Pacira BioSciences (PCRX) Payables (2010 - 2026)
Pacira BioSciences (PCRX) recorded Payables of $17.51 million in Q2 2026, down 41.9% from $30.12 million a year earlier but up 25.0% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Pacira BioSciences reported Payables of $15.15 million, down 20.8% from FY2024.
- Annual Payables has a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
- Across earlier years, Payables came in at $19.13 million in FY2024 (+21.9%), $15.7 million in FY2023 (+3.1%), $15.22 million in FY2022 (+44.4%) and $10.54 million in FY2021 (+1.1%).
- Quarterly Payables has ranged from $7.9 million in Q3 2021 to $30.12 million in Q2 2025 over the past five years.
- On a year-over-year basis, Payables has declined for four consecutive quarters, with growth averaging 18.4% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 158.0% in Q1 2025, against a decline of 48.0% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $14.01 million (Q1 2026), $15.15 million (Q4 2025) and $17.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Pacira BioSciences | 1.01 Bn | 73.12 Mn | 148.24 Mn | 17.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.51 Mn |
| Mar 31, 2026 | 14.01 Mn |
| Dec 31, 2025 | 15.15 Mn |
| Sep 30, 2025 | 17.69 Mn |
| Jun 30, 2025 | 30.12 Mn |
| Mar 31, 2025 | 23.17 Mn |
| Dec 31, 2024 | 19.13 Mn |
| Sep 30, 2024 | 19.37 Mn |
| Jun 30, 2024 | 18.73 Mn |
| Mar 31, 2024 | 8.98 Mn |
| Dec 31, 2023 | 15.70 Mn |
| Sep 30, 2023 | 16.51 Mn |
| Jun 30, 2023 | 24.21 Mn |
| Mar 31, 2023 | 17.26 Mn |
| Dec 31, 2022 | 15.22 Mn |
| Sep 30, 2022 | 12.93 Mn |
| Jun 30, 2022 | 13.98 Mn |
| Mar 31, 2022 | 14.84 Mn |
| Dec 31, 2021 | 10.54 Mn |
| Sep 30, 2021 | 7.90 Mn |
API Access
Pacira BioSciences Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();